
Cure-Z Pharma Private Limited
Founded in March 2025 and headquartered in Bihar, India.
Founded in March 2025 and headquartered in Bihar, India.
Cure-Z Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 March 2025 ( two months 27 days old ). Its registered office is in Patna, Bihar, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Zahir Abbas, Sarita Devi, and Fatima Anis serve as directors at the Company.
Patna, Bihar, India
+91-XXXXXXXXXX
U46497BR2025PTC074325
074325
Private Limited Indian Non-Government Company
08 Mar 2025
-
-
Unlisted
Roc Patna
Name | Designation | Appointment Date | Status |
---|---|---|---|
Zahir Abbas | Managing Director | 08-Mar-2025 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sarita Devi | Director | 08-Mar-2025 | Current |
Fatima Anis | Director | 08-Mar-2025 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Cure-Z Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cure-Z Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cure-Z Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure-Z Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Zahir Abbas was appointed as a Managing Director was appointed as a Managing Director on 08 Mar 2025 & has been associated with this company since 2 months 27 days .
Sarita Devi was appointed as a Director was appointed as a Director on 08 Mar 2025 & has been associated with this company since 2 months 27 days .
Fatima Anis was appointed as a Director was appointed as a Director on 08 Mar 2025 & has been associated with this company since 2 months 27 days .
Cure-Z Pharma Private Limited was registered on 08 Mar 2025 with Roc Patna & aged 2 months 27 days as per MCA records.
Cure-Z Pharma Private Limited was incorporated on 08 Mar 2025.
The authorized share capital of Cure-Z Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Currently 3 directors are associated with Cure-Z Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cure-Z Pharma Private Limited is H No. 192 Road No 14 Lane 5, Kankarbagh India, Sampatchak, Bihar, 800020.
The corporate identification number (CIN) of Cure-Z Pharma Private Limited is U46497BR2025PTC074325 and the company number is 074325 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.